Highlights LB Pharmaceuticals Inc

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-06 pm EST			5-day change	1st Jan Change
23.78 ^USD	+0.98%		-0.96%	+6.83%

Feb. 05	LB Pharmaceuticals announces $100.0 million private placement	RE
Feb. 05	LB Pharmaceuticals Plans $100 Million Private Placement	MT

Jan. 26	LB Pharmaceuticals Inc. Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 Development Program	CI
Jan. 21	LB Pharmaceuticals Inc Appoints Minako Pazdera as General Counsel	CI
Dec. 19	Aktis Oncology files for US IPO as biotech listings rebound	RE
Nov. 06	LB Pharmaceuticals Inc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-10-27	Novo-backed MapLight valued at $787 million after shares jump in Nasdaq debut	RE
25-10-26	Drug developer MapLight Therapeutics valued at $704.3 million after US IPO	RE
25-09-10	LB Pharmaceuticals Inc has completed an IPO in the amount of $285 million.	CI